Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Deggendorf

20 clinical trials in Deggendorf, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Deggendorf at a glance
20
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

20 trials in Deggendorf

Open in trial search
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sapablursen
  • Sponsor:Deciphera Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Eikon Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:BeOne Medicines I GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Swiss GO Trial Group
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Polyneuropathy

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Wala-Heilmittel GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Krankenhaus Nordwest GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Deggendorf

What the registry says about research in the country

01 Breast Cancer Research

Groundbreaking studies focusing on triple-negative breast cancer and HER2-negative breast cancer treatments, investigating novel therapeutic approaches including immunotherapy and targeted treatments.

  • Neoadjuvant chemotherapy combinations
  • Targeted therapies for specific mutations
  • Post-treatment survival improvements

Multiple trials exploring innovative treatment strategies for various breast cancer subtypes.

02 Gastrointestinal Oncology

Comprehensive research into colorectal cancer and gastric adenocarcinoma, evaluating both early-stage treatments and advanced disease management strategies.

  • Metastatic disease treatment
  • Post-resection therapy
  • Novel drug combinations

Studies aim to improve survival rates and treatment outcomes across different disease stages.

03 Hematologic Malignancies

Innovative trials examining treatments for chronic lymphocytic leukemia, with special focus on elderly patients and those with high-risk genetic profiles.

  • Targeted therapies
  • Age-specific treatments
  • Genetic risk factor studies

Research emphasizes personalized treatment approaches based on genetic markers.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.